Catheter-based renal denervation is a promising contemporary evolution of a historical treatment for hypertension and aims to achieve a reduction in renal sympathetic activation. This has been ...

A minimally invasive procedure used to treat resistant hypertension or high blood pressure that does not respond to other medications, renal denervation disrupts the nerves in the renal arteries, ...

The Symplicity studies suggest that intravascular renal sympathetic nervous denervation improves blood pressure in patients with resistant hypertension, thus potentially opening a market for ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Nothing doctors prescribed controlled Michael Garrity’s dangerously high blood pressure — until they zapped away some nerves ...

Just hours earlier, the Centers for Medicare and Medicaid Services (CMS) had informed the company that it was opening a national coverage analysis of renal denervation and a final decision will be ...

Mount Carmel’s heart and vascular teams have debuted several new, highly advanced surgical procedures in Central Ohio.

Opens in a new tab or window The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation for patients with hypertension ...

About the Paradise uRDN System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN technology designed to lower blood pressure by denervating the sympathetic nerves surrounding ...

This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to the Symplicity™ Spyral renal denervation (RDN) system ...